The Claim
This lawsuit claims that four major pharmaceutical companies sold cold medications marketed as decongestants, despite the active ingredient, phenylephrine, being found ineffective in pill form. The case follows a U.S. FDA ruling that phenylephrine has no decongestant effect, despite decades of marketing otherwise. The suit seeks damages for misleading consumers into buying these products, many of which continue to be sold in Canada, and alleges that companies knowingly concealed the truth to protect profits.
The Class
This case seeks to represent people who have ever purchased any of the following cold medicines:
- Benylin Extra Strength Cold & Sinus
- Benylin D for Infants
- Contac Cold Nasal Congestion
- Contac Cold & Sinus Extra Strength
- Contac Cold & Sinus Hot Medicated Drink
- Contac Extra Strength Cold & Sinus Hot Medicated Drink
- Contac Super Strength Cold & Sinus Hot Medicated Drink
- DayQuil Cold & Flu
- DayQuil Sinus Liquicaps
- NeoCitran Extra Strength Cold & Congestion
- NeoCitran Extra Strength Total Cold
- Robitussin Complete
- Sudafed PE Extra Strength
- Triaminic Thin Strips Cold & Cough
- Triaminic Thin Strips Nasal Congestion
- Triaminic Thin Strips Nighttime Cold & Cough
- Tylenol Cold and Flu
- Tylenol Cold Rapid Release
- Tylenol Extra Strength Cold
- Tylenol Extra Strength Flu
- Tylenol Extra Strength Sinus
- Tylenol Regular Strength Cold
- Tylenol Regular Strength Sinus
- Tylenol Sinus Liquicaps
- Vicks Custom Care Nasal Congestion
- Vicks Sinex Pressure & Pain
- Vicks DayQuil Cold & Flu Multi-Symptom Relief Liquicaps
- Vicks DayQuil Hot Remedy
Partners
We are working with Sotos Class Actions to bring this claim
